You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 1, January 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (54)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Corneal Disorders
 •Alert me on articles by topic

Immunolocalization of {beta}ig-h3 Protein in 5q31-Linked Corneal Dystrophies and Normal Corneas

Barbara W. Streeten, MD; Yue Qi, MD; Gordon K. Klintworth, MD, PhD; Ralph C. Eagle, Jr, MD; Judith A. Strauss, BS; Kelly Bennett, PhD

Arch Ophthalmol. 1999;117:67-75.

Objective  To characterize the relation of the {beta}ig-h3 protein to the diagnostic corneal deposits in the hereditary corneal dystrophies recently shown to have mutations in the {beta}ig-h3 gene on chromosome 5q31.

Methods  Corneas with lattice, granular, mixed granular-lattice ("Avellino"), and 2 types of Reis-Bücklers dystrophy were diagnosed by the histochemical and ultrastructural characteristics of their abnormal aggregates. Dystrophic and normal corneas were compared for immunolocalization of {beta}ig-h3 protein.

Results  In normal corneas, immunoreactivity for {beta}ig-h3 protein was strongest in the Bowman layer, and next strong along stromal interlamellar junctions and attachment sites of collagen to the Descemet membrane. Antibody binding was intense on all dystrophic aggregates, mimicking somewhat the normal protein distribution. Mixed granular-lattice dystrophy had the most variation in {beta}ig-h3–immunopositive forms. The aggregates in both the "rod-shaped" Reis-Bücklers type and the "curly fiber" Thiel-Behnke type were strongly stained for {beta}ig-h3 protein, consistent with mutations on the {beta}ig-h3 gene.

Conclusions  The marked immunopositivity for {beta}ig-h3 protein in the abnormal deposits in these dystrophies indicates that {beta}ig-h3 protein is a major component. The variety and quantity of immunopositive forms suggests that they consist primarily of the mutant protein, self-polymerizing and/or incorrectly binding to other corneal components. Variability of forms may relate to both the specific mutation and regional interactions of this protein.


From the Departments of Ophthalmology and Pathology, State University of New York Health Science Center, Syracuse (Drs Streeten and Qi and Ms Strauss); Duke University Eye Center, Durham, NC (Dr Klintworth); Wills Eye Hospital, Philadelphia, Pa (Dr Eagle); and Pharmaceutical Research Institute, Bristol-Myers Squibb Corp, Princeton, NJ (Dr Bennett).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Novel Variant of Combined Granular-Lattice Corneal Dystrophy Associated With the Met619Lys Mutation in the TGFBI Gene
Aldave et al.
Arch Ophthalmol 2008;126:371-377.
ABSTRACT | FULL TEXT  

betaig-h3 Interacts Directly with Biglycan and Decorin, Promotes Collagen VI Aggregation, and Participates in Ternary Complexing with These Macromolecules
Reinboth et al.
J. Biol. Chem. 2006;281:7816-7824.
ABSTRACT | FULL TEXT  

Genotype-Phenotype Correlation in 2 Indian Families With Severe Granular Corneal Dystrophy
Kannabiran et al.
Arch Ophthalmol 2005;123:1127-1133.
ABSTRACT | FULL TEXT  

Two Mutations in the TGFBI (BIGH3) Gene Associated with Lattice Corneal Dystrophy in an Extensively Studied Family
Klintworth et al.
IOVS 2004;45:1382-1388.
ABSTRACT | FULL TEXT  

Covalent and Non-covalent Interactions of {beta}ig-h3 with Collagen VI: {beta}ig-h3 IS COVALENTLY ATTACHED TO THE AMINO-TERMINAL REGION OF COLLAGEN VI IN TISSUE MICROFIBRILS
Hanssen et al.
J. Biol. Chem. 2003;278:24334-24341.
ABSTRACT | FULL TEXT  

Unusual Superficial Variant of Granular Corneal Dystrophy With Amyloid Deposition
Mathew et al.
Arch Ophthalmol 2003;121:269-271.
FULL TEXT  

Medical Applications of Transforming Growth Factor-{beta}
Flanders and Burmester
Clin Med Res 2003;1:13-20.
ABSTRACT | FULL TEXT  

Molecular Properties of Wild-Type and Mutant {beta}IG-H3 Proteins
Kim et al.
IOVS 2002;43:656-661.
ABSTRACT | FULL TEXT  

Clinical and morphological features including expression of {beta}ig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea
Akhtar et al.
Br. J. Ophthalmol. 2002;86:147-151.
ABSTRACT | FULL TEXT  

Ultrastructural morphology and expression of proteoglycans, {beta}ig-h3, tenascin-C, fibrillin-1, and fibronectin in bullous keratopathy
Akhtar et al.
Br. J. Ophthalmol. 2001;85:720-731.
ABSTRACT | FULL TEXT  

Survey of Patients With Granular, Lattice, Avellino, and Reis-Bucklers Corneal Dystrophies for Mutations in the BIGH3 and Gelsolin Genes
Afshari et al.
Arch Ophthalmol 2001;119:16-22.
ABSTRACT | FULL TEXT  

Corneal Dystrophies of Epithelial Genesis: The Possible Therapeutic Use of Limbal Stem Cell Transplantation
Dunaief et al.
Arch Ophthalmol 2001;119:120-122.
FULL TEXT  

Overexpression of the Transforming Growth Factor-{beta}-Inducible Gene {beta}ig-h3 in Anterior Polar Cataracts
Lee et al.
IOVS 2000;41:1840-1845.
ABSTRACT | FULL TEXT  

Corneal amyloidosis caused by Leu518Pro mutation of beta ig-h3 gene
Hirano et al.
Br. J. Ophthalmol. 2000;84:583-585.
ABSTRACT | FULL TEXT  

BIGH3 Exon 14 Mutations Lead to Intermediate Type I/IIIA of Lattice Corneal Dystrophies
Schmitt–Bernard et al.
IOVS 2000;41:1302-1308.
ABSTRACT | FULL TEXT  

Amyloid and Non-amyloid Forms of 5q31-linked Corneal Dystrophy Resulting from Kerato-epithelin Mutations at Arg-124 Are Associated with Abnormal Turnover of the Protein
Korvatska et al.
J. Biol. Chem. 2000;275:11465-11469.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.